Filing Flows › Health Care › Target Group (CBDY)
Target Group (CBDY) earnings and revenue breakdown
Latest: Q2 2026 · 10-Q filed Aug 13, 2026 · Target Group (CBDY) Q2 2026 earnings results →
Q2 2026 Revenue up 11% year over year to $1.4M · 17¢ of every $1 of revenue lost · operating margin -17.4%
Target Group made $1.4M in Q2 2026 (+11% Y/Y). Operating margin -17.4%, net loss $240K. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 13, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $1.4M in Q2 2026, up 11% year over year and up 57% from the previous quarter.
Gross margin was 45.5%, down 14.3 points from Q2 2025. Operating costs exceeded revenue by $240K, an operating margin of -17.4%. Operating expenses fell 10% while revenue rose 11%. The quarter ended with a net loss of $240K, narrower than the previous quarter's $550K loss.
Operating cash flow was −$223K. Non-cash charges added back $229K of depreciation. Working capital and other items used $212K.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 10-Q | Aug 13, 2026 | $1.4M | +11% | -17.4% | −$240K | −$223K |
| Q1 2026 | 10-Q | May 15, 2026 | $879K | -37% | -62.6% | −$550K | −$94K |
| Q4 2025 | 10-K | Mar 31, 2026 | $735K | -60% | -75.1% | −$552K | −$251K |
| Q3 2025 | 10-Q | Nov 7, 2025 | $500K | -8% | -95.9% | −$479K | −$506K |
| Q2 2025 | 10-Q | Aug 12, 2025 | $1.2M | -45% | -17.6% | −$220K | $484K |
| Q1 2025 | 10-Q | May 9, 2025 | $1.4M | -27% | -7.7% | −$108K | −$570K |
| Q4 2024 | 10-K | Mar 27, 2025 | $1.9M | -3% | 11.6% | $216K | $736K |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About Target Group
Target Group Inc. (“Target Group” or the “Company”) was incorporated in the State of Delaware on July 2, 2013, under its original name of River Run Acquisition Corporation. Effective May 13, 2014, the Company changed its name to Chess Supersite Corporation. On July 3, 2018, the Company filed an amendment in its Certificate of Incorporation to change its name to Target Group Inc. Effective July 1, 2025, the Company’s common stock is quoted on the Pink Limited Market operated by OTC Markets Group Inc, under the symbol “CBDY”.
In its own words, from its 10-K, filed Mar 31, 2026.
Target Group against its Medicinal Chemicals & Botanical Products peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +11% against the peers' median +11%. Operating margin: -17.4% against the peers' median 0.8%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| CBDY Target Group | Q2 2026 | $1.4M | +11% | -17.4% |
| CURLF Curaleaf Holdings | Q3 2026 | $353M | +11% | 0.8% |
| TLRY Tilray Brands | Q1 FY27 | $257M | +23% | -9.4% |
| TRLV Trulieve Cannabis | Q3 2026 | $230M | -20% | 18.5% |
| USNA Usana Health Sciences | Q2 2026 | $223M | -5% | -9.0% |
| AAWH Ascend Wellness Holdings | Q2 2026 | $126M | -0.9% | 4.2% |
| CRON Cronos Group | Q3 2026 | $83.9M | +72% | 10.8% |
| CGC Canopy Growth | Q2 FY27 | $71.1M | +20% | -23.1% |
| JUSH Jushi Holdings | Q3 2026 | $70.5M | +7% | 5.0% |
Source: Target Group 10-Q on SEC EDGAR · CIK 1586554 · Medicinal Chemicals & Botanical Products
More on CBDY
History
Every quarter: Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results · Q4 2024 results